Kinematic analysis reliably assesses GPi-DBS effectiveness in dystonia
Edouard Courtin1,2, Juliette Thomas3, Etienne Guillaud4
1Service de neurophysiologie clinique de l'enfant et de l'adulte, CHU de Bordeaux, Bordeaux, France edouard.courtin@chu-bordeaux.fr.
Journal of Neurology, Neurosurgery, and Psychiatry
|January 2, 2026
Summary
Deep brain stimulation (DBS) effectively treats dystonia. Three-dimensional (3D) kinematic analysis reveals objective biomarkers for globus pallidus interna (GPi)-DBS effectiveness, aiding personalized treatment assessment.
Area of Science:
- Neurology
- Biomedical Engineering
- Movement Disorders
Background:
- Deep brain stimulation (DBS) of the globus pallidus interna (GPi) is effective for severe generalized (GD) or cervical dystonia (CD).
- Objective assessment of GPi-DBS effectiveness in dystonia remains a challenge.
Purpose of the Study:
- To identify objective biomarkers of GPi-DBS effectiveness.
- Utilize a minimalistic three-dimensional (3D) kinematic motion capture system for this assessment in dystonia patients.
Main Methods:
- Retrospective analysis of kinematic data from 14 patients (7 GD, 7 CD) before and after GPi-DBS.
- Measured parameters included barycentre displacement, volume, velocity, angular velocity, and power spectral density (PSD).
- Dystonia severity was quantified using the Burke-Fahn-Marsden (BFM) scale.
Main Results:
- GPi-DBS significantly reduced overall dystonia severity (mean BFM decrease from 21.6 to 14.1).
- Kinematic analysis showed a significant reduction in barycentre angular velocity across all patients.
- Significant improvements in displacement length, velocity, and PSD were observed in the CD subgroup, correlating with clinical improvements.
Conclusions:
- Three-dimensional (3D) kinematic analysis offers objective biomarkers for assessing GPi-DBS effectiveness in dystonia.
- Kinematic features provide valuable information for individualized outcome assessment, irrespective of dystonia phenotype.
